Relapse frequency in transitioning from natalizumab to dimethyl fumarate: assessment of risk factors.
about
Relapse frequency in transitioning from natalizumab to dimethyl fumarate: assessment of risk factors.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Relapse frequency in transitio ...... e: assessment of risk factors.
@en
type
label
Relapse frequency in transitio ...... e: assessment of risk factors.
@en
prefLabel
Relapse frequency in transitio ...... e: assessment of risk factors.
@en
P2093
P2860
P1433
P1476
Relapse frequency in transitio ...... e: assessment of risk factors.
@en
P2093
Ashley Flinn
Jonathan Zurawski
Lindsay Sklover
P2860
P2888
P304
P356
10.1007/S00415-016-8162-8
P577
2016-05-18T00:00:00Z